Invivyd, Inc. (IVVD)
USD 0.53
(-4.24%)
USD 0.53
(-4.24%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -198.47 Million USD | -124.64% |
| 2022 | -88.35 Million USD | 83.71% |
| 2021 | -542.22 Million USD | -371.55% |
| 2020 | -114.98 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -187.62 Million USD | 5.47% |
| 2024 Q2 | -147.2 Million USD | 21.55% |
| 2023 Q3 | -179.25 Million USD | -50.65% |
| 2023 FY | -198.47 Million USD | -124.64% |
| 2023 Q1 | -123.13 Million USD | -39.36% |
| 2023 Q2 | -118.99 Million USD | 3.36% |
| 2023 Q4 | -198.47 Million USD | -10.72% |
| 2022 FY | -88.35 Million USD | 83.71% |
| 2022 Q4 | -88.35 Million USD | 68.06% |
| 2022 Q3 | -276.64 Million USD | 41.39% |
| 2022 Q2 | -472.02 Million USD | 11.03% |
| 2022 Q1 | -530.56 Million USD | 2.15% |
| 2021 Q4 | -542.22 Million USD | -13.37% |
| 2021 FY | -542.22 Million USD | -371.55% |
| 2021 Q2 | -392.5 Million USD | -330.16% |
| 2021 Q1 | -91.24 Million USD | 20.65% |
| 2021 Q3 | -478.26 Million USD | -21.85% |
| 2020 FY | -114.98 Million USD | 0.0% |
| 2020 Q4 | -114.98 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -254.802% |
| Alkermes plc | -166.73 Million USD | -19.034% |
| Agenus Inc. | 274.13 Million USD | 172.401% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 110.614% |
| Aptorum Group Limited | 1.35 Million USD | 14725.591% |
| Ardelyx, Inc. | 34.51 Million USD | 675.093% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4737.29% |
| Bicycle Therapeutics plc | -481.46 Million USD | 58.777% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 648.837% |
| ChromaDex Corporation | -24.04 Million USD | -725.333% |
| Chimerix, Inc. | -25.51 Million USD | -677.819% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2948.362% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -738.265% |
| CRISPR Therapeutics AG | -150.84 Million USD | -31.576% |
| Precision BioSciences, Inc. | -85.41 Million USD | -132.38% |
| Dyadic International, Inc. | -6.37 Million USD | -3011.836% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1145.691% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2689.38% |
| Lantern Pharma Inc. | -21.7 Million USD | -814.498% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -79.556% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2223.211% |
| Incyte Corporation | -3.17 Billion USD | 93.749% |
| IO Biotech, Inc. | -140.69 Million USD | -41.064% |
| Jaguar Health, Inc. | 29.39 Million USD | 775.295% |
| Novavax, Inc. | -298.29 Million USD | 33.463% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3818.868% |
| Opthea Limited | 28.15 Million USD | 804.879% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1082.179% |
| ContextLogic Inc. | -232 Million USD | 14.45% |
| MiMedx Group, Inc. | -33.9 Million USD | -485.458% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2046.797% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -8465.977% |
| NextCure, Inc. | -6.47 Million USD | -2964.32% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -293.014% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3011.397% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1731.766% |
| Vaxcyte, Inc. | -368.22 Million USD | 46.1% |
| PDS Biotechnology Corporation | -32.7 Million USD | -506.795% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1248.721% |
| Pharming Group N.V. | 109.8 Million USD | 280.755% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1040.929% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -13.266% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -971.693% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -971.693% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2695.437% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3286.962% |
| Acelyrin, Inc. | -216.9 Million USD | 8.496% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3437.728% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -11412.529% |
| Summit Therapeutics Inc. | 34.67 Million USD | 672.406% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2817.478% |
| Senti Biosciences, Inc. | 1.74 Million USD | 11506.667% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -7.513% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -156.26% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3174.101% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 199035.541% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 31704.459% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -69.571% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -17.977% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 279.017% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2512.902% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -53.722% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2978.718% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 18.108% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1033.514% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 37.331% |
| MEI Pharma, Inc. | -3.7 Million USD | -5256.977% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1686.412% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 222.711% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 814.122% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2689.38% |
| Precigen, Inc. | -481 Thousand USD | -41163.202% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1509.531% |
| AlloVir, Inc. | -62.69 Million USD | -216.589% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -256.881% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 421.856% |
| ImmuCell Corporation | 10.99 Million USD | 1905.877% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -28.758% |
| Onconetix, Inc. | 5.33 Million USD | 3822.749% |
| PureTech Health plc | -167.19 Million USD | -18.708% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -551.596% |
| Elevation Oncology, Inc. | -19.11 Million USD | -938.163% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3943.105% |
| Seer, Inc. | -4.24 Million USD | -4581.038% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -725.71% |
| Innoviva, Inc. | 255.56 Million USD | 177.662% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -255.284% |
| ESSA Pharma Inc. | -33.62 Million USD | -490.323% |
| GlycoMimetics, Inc. | -40.98 Million USD | -384.272% |
| GT Biopharma, Inc. | -1.02 Million USD | -19339.373% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -192.811% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 424.005% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -48.029% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1332.419% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -587.434% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -263361.385% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -543.108% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2321.958% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -6243.076% |
| Soligenix, Inc. | -4.95 Million USD | -3908.323% |
| Century Therapeutics, Inc. | 847 Thousand USD | 23532.822% |
| Kura Oncology, Inc. | -20.11 Million USD | -886.559% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -384.963% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2263.372% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 10995.128% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -6108.195% |
| Autolus Therapeutics plc | -186.59 Million USD | -6.365% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -302.556% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 28.035% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 679.188% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 220.751% |
| GRI Bio, Inc. | -1.79 Million USD | -10963.322% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2109.451% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -496.795% |
| IGM Biosciences, Inc. | -72.6 Million USD | -173.36% |
| INmune Bio, Inc. | -25.41 Million USD | -681.063% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 231.484% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -291.788% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1121.438% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -6779.761% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 622.099% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -381.913% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 722.475% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 152.514% |
| Verastem, Inc. | -37.27 Million USD | -432.421% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2087.545% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -282.7% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1211.371% |
| Histogen Inc. | -7.48 Million USD | -2550.942% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -818.58% |
| Surrozen, Inc. | -32.66 Million USD | -507.629% |
| Organovo Holdings, Inc. | -1.5 Million USD | -13070.272% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4621.698% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1146.803% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 7687.003% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4875.65% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2268.124% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -356.876% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1261.583% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 37.348% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -27387.466% |
| Apollomics, Inc. | -27.39 Million USD | -624.497% |
| Amarin Corporation plc | -191.04 Million USD | -3.892% |
| Mesoblast Limited | 55.96 Million USD | 454.656% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1260.916% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -684.738% |
| Synaptogenix, Inc. | -28.66 Million USD | -592.483% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -21104.701% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 507.281% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -22922.681% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2631.542% |
| Exelixis, Inc. | -73.05 Million USD | -171.699% |
| Better Therapeutics, Inc. | -860 Thousand USD | -22978.605% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -726.536% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 17.771% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 27064.43% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2568.357% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 15927.432% |
| Gritstone bio, Inc. | 39.49 Million USD | 602.598% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -135.997% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -7440.48% |
| Avid Bioservices, Inc. | 169.72 Million USD | 216.938% |
| Insmed Incorporated | 721.62 Million USD | 127.504% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2071.151% |
| MediWound Ltd. | -5.32 Million USD | -3629.35% |
| OmniAb, Inc. | 9.2 Million USD | 2256.645% |
| Alector, Inc. | -35.63 Million USD | -456.938% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 330.864% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3927.516% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1599.177% |
| Zai Lab Limited | -775 Million USD | 74.39% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 158.28% |
| Aura Biosciences, Inc. | -21.52 Million USD | -822.072% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -140.635% |
| Immunic, Inc. | -45.34 Million USD | -337.75% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -2.723% |
| Veracyte, Inc. | -203.82 Million USD | 2.624% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 131.095% |
| FibroGen, Inc. | 56.76 Million USD | 449.633% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2328.815% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -6920.525% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -9486.601% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.324% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5840.617% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -19.59% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1211.163% |
| Galecto, Inc. | -21.21 Million USD | -835.502% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -734.459% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 112.647% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -711.033% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1624.828% |
| XBiotech Inc. | -200.02 Million USD | 0.773% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -135.997% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4483.304% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -462.845% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -157.033% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3587.542% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -16.466% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -114.861% |
| Vaxxinity, Inc. | 10.13 Million USD | 2058.902% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 126.957% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1743.279% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -200.922% |
| NexImmune, Inc. | -3.13 Million USD | -6233.714% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -5648.474% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1213.415% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -632.384% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2111.172% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -159222.496% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -389.195% |
| Ainos, Inc. | 4.07 Million USD | 4967.08% |
| Pluri Inc. | 22.82 Million USD | 969.403% |
| Prothena Corporation plc | -608.34 Million USD | 67.375% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -67.129% |
| Celularity Inc. | 65.19 Million USD | 404.458% |
| Rallybio Corporation | -24.1 Million USD | -723.484% |
| Cue Biopharma, Inc. | -33.81 Million USD | -486.877% |
| MeiraGTx Holdings plc | -40.3 Million USD | -392.472% |
| Omeros Corporation | 331.17 Million USD | 159.931% |
| Humacyte, Inc. | -22.48 Million USD | -782.665% |
| Immunocore Holdings plc | -358.59 Million USD | 44.652% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -707.634% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -542.296% |
| Blueprint Medicines Corporation | 702.83 Million USD | 128.239% |
| CalciMedica, Inc. | -5.53 Million USD | -3489.078% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -5.449% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1843.176% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -395.731% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -496.866% |
| Pulmatrix, Inc. | -10.41 Million USD | -1805.309% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3220.663% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -420.361% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -78.162% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -231.102% |
| Cytokinetics, Incorporated | 642.37 Million USD | 130.897% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3308.484% |
| Nutriband Inc. | -251.65 Thousand USD | -78767.665% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -481.717% |
| Vor Biopharma Inc. | 4.3 Million USD | 4715.721% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.712% |
| Evogene Ltd. | -19.63 Million USD | -910.879% |
| ProKidney Corp. | -56.23 Million USD | -252.934% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -307.783% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2048.663% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 114.552% |
| CorMedix Inc. | -43.05 Million USD | -361.009% |
| BioLineRx Ltd. | 7.33 Million USD | 2805.507% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -622.651% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 530.095% |
| Atai Life Sciences N.V. | -28.55 Million USD | -594.993% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 8998.158% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -769.898% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1219.12% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -164.374% |
| MediciNova, Inc. | -50.78 Million USD | -290.828% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -151.857% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -882211.625% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2975.913% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 0.673% |
| Biomea Fusion, Inc. | -166.57 Million USD | -19.155% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -10.896% |
| Mereo BioPharma Group plc | -51.46 Million USD | -285.622% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -109.266% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 32.436% |
| Absci Corporation | -72.59 Million USD | -173.39% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4446.824% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 15.339% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -110.672% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -107.403% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -407.962% |
| Allakos Inc. | -24.97 Million USD | -694.699% |
| Imunon, Inc. | -4.21 Million USD | -4610.085% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1246.33% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -46.585% |
| BioAtla, Inc. | -109.01 Million USD | -82.07% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 27064.43% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -21036.954% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1758.666% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -836.075% |
| XOMA Corporation | -29 Million USD | -584.4% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1098.527% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2101.375% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2564.465% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -59.245% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 4.654% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -142.698% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -113.96% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -23000.523% |
| Akari Therapeutics, Plc | -3.84 Million USD | -5061.925% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12329.788% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 114.373% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -16604.836% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4620.064% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 274.898% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 275906.676% |
| Orgenesis Inc. | 21.78 Million USD | 1011.109% |
| Entera Bio Ltd. | -10.62 Million USD | -1767.306% |
| GH Research PLC | -78.07 Million USD | -154.205% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -790.506% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -644.499% |
| Xencor, Inc. | 29.64 Million USD | 769.532% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -9975.885% |
| Replimune Group, Inc. | 1.41 Million USD | 14156.374% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -80941.044% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -57.001% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -16604.836% |
| Portage Biotech Inc. | -4.98 Million USD | -3884.662% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -882211.625% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -200.166% |
| OncoCyte Corporation | -6.56 Million USD | -2924.166% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 22216.461% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4256.707% |
| Purple Biotech Ltd. | -14.13 Million USD | -1303.848% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -735.477% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2932.483% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1089.037% |
| HilleVax, Inc. | -165.48 Million USD | -19.936% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -7720.173% |
| Tharimmune, Inc. | -10.93 Million USD | -1714.994% |
| Genprex, Inc. | -6.73 Million USD | -2845.784% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 46.184% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -124.368% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -14066.738% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5883.697% |
| OKYO Pharma Limited | -826.84 Thousand USD | -23903.928% |
| Savara Inc. | 153 Thousand USD | 129822.876% |
| Curis, Inc. | -23.88 Million USD | -730.895% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3747.992% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -25476.409% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3097.101% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 16849.03% |
| BeiGene, Ltd. | -2.25 Billion USD | 91.191% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1708.591% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 67.367% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -6.946% |
| Erasca, Inc. | -37.21 Million USD | -433.308% |
| bluebird bio, Inc. | 108.57 Million USD | 282.808% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -15310.908% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 152.403% |
| DBV Technologies S.A. | -126.98 Million USD | -56.298% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -15310.908% |
| Moderna, Inc. | -2.9 Billion USD | 93.172% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1817.272% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1726.242% |
| Molecular Templates, Inc. | 707 Thousand USD | 28172.984% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -532.673% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 157.262% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -141.861% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -116.37% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -515.01% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -477.368% |
| MacroGenics, Inc. | -66.98 Million USD | -196.299% |
| RenovoRx, Inc. | -1.17 Million USD | -16820.375% |
| Adicet Bio, Inc. | -138.78 Million USD | -43.008% |
| Prime Medicine, Inc. | -27.94 Million USD | -610.34% |
| Aditxt, Inc. | 18.12 Million USD | 1195.289% |
| Adagene Inc. | -87.62 Million USD | -126.5% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4664.84% |
| Quantum-Si incorporated | -118.55 Million USD | -67.41% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 651.246% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2555.486% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -309.153% |
| SciSparc Ltd. | -2.06 Million USD | -9511.429% |
| Vericel Corporation | 1.27 Million USD | 15642.365% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1555.111% |
| Minerva Neurosciences, Inc. | 41 Million USD | 584.038% |
| Generation Bio Co. | 31.44 Million USD | 731.124% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -13.179% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -541.839% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 270.23% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -119.869% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -8177.807% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -180.373% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2808.073% |
| 2seventy bio, Inc. | 181.71 Million USD | 209.224% |
| ADMA Biologics, Inc. | 90.06 Million USD | 320.367% |
| Clene Inc. | 3.34 Million USD | 6042.395% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2085.209% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -822.672% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2975.913% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 42.324% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -663.379% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 211.713% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4750.855% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 4067.933% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3710.251% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -52.318% |
| Evaxion Biotech A/S | 5.28 Million USD | 3854.149% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -76.317% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -51.193% |
| Trevena, Inc. | 2.25 Million USD | 8889.903% |
| Surrozen, Inc. | -32.66 Million USD | -507.629% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -285.315% |
| Cingulate Inc. | 3.08 Million USD | 6538.417% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -6657.78% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2861.597% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2036.166% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -150.212% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -50.987% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -88.054% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4934.093% |
| Kronos Bio, Inc. | -36.05 Million USD | -450.496% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2209.427% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13711.709% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -265.814% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1476.737% |
| ImmunityBio, Inc. | 618.22 Million USD | 132.104% |
| Korro Bio, Inc. | -132.94 Million USD | -49.294% |
| Kineta, Inc. | -4.54 Million USD | -4270.755% |
| BioVie Inc. | -17.73 Million USD | -1019.288% |
| Codexis, Inc. | -43.27 Million USD | -358.681% |
| Celularity Inc. | 65.19 Million USD | 404.458% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -6163.048% |
| Celcuity Inc. | 6.78 Million USD | 3025.86% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5798.345% |
| Cibus, Inc. | -8.07 Million USD | -2356.994% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4593.214% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4443.02% |
| IN8bio, Inc. | -16.38 Million USD | -1111.032% |
| Kodiak Sciences Inc. | -103.87 Million USD | -91.072% |
| Annexon, Inc. | -193.75 Million USD | -2.437% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 551422.222% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1034.213% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -5549.758% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 118.826% |
| Eyenovia, Inc. | 1.25 Million USD | 15868.307% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 837.692% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6020.136% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -496.974% |
| Arcellx, Inc. | -296.95 Million USD | 33.164% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -917.513% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -237.114% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -857.572% |
| Moolec Science SA | 117.61 Thousand USD | 168849.15% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -416.878% |
| Geron Corporation | 14.76 Million USD | 1444.597% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -423.435% |
| Royalty Pharma plc | 5.65 Billion USD | 103.508% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -40.344% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2739.662% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3600.936% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -41.032% |
| Humacyte, Inc. | -22.48 Million USD | -782.665% |
| Structure Therapeutics Inc. | -124.33 Million USD | -59.625% |
| 89bio, Inc. | -289.05 Million USD | 31.336% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -686.293% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -11031.576% |
| Genelux Corporation | -6.89 Million USD | -2776.881% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -539.029% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 337.414% |
| Notable Labs, Ltd. | -9.77 Million USD | -1930.237% |
| Liquidia Corporation | -80.17 Million USD | -147.55% |
| Mustang Bio, Inc. | -3.73 Million USD | -5212.527% |
| Immunovant, Inc. | -635.22 Million USD | 68.755% |
| Quantum-Si incorporated | -118.55 Million USD | -67.41% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1030.016% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4690.635% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2572.605% |
| Acasti Pharma Inc. | -23 Million USD | -762.752% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5794.342% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1121.438% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -44.095% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -6268.836% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -792.749% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -968.857% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -17.249% |
| PepGen Inc. | -60.67 Million USD | -227.14% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -763.841% |
| United Therapeutics Corporation | -507.7 Million USD | 60.907% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -937.729% |
| Solid Biosciences Inc. | -47.75 Million USD | -315.657% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -22922.681% |
| Immuneering Corporation | -54.94 Million USD | -261.241% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4621.698% |
| Silo Pharma, Inc. | -3.52 Million USD | -5531.63% |
| Belite Bio, Inc | -87.27 Million USD | -127.425% |
| XOMA Corporation | -29 Million USD | -584.4% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -180.742% |
| Bionomics Limited | 227 Million USD | 187.431% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -70.685% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7735.61% |
| uniQure N.V. | -102.95 Million USD | -92.787% |
| Cassava Sciences, Inc. | -121.13 Million USD | -63.846% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4664.84% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 584.667% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1559.36% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -6314.453% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 187341.509% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6020.136% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2328.815% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2576.321% |
| Altimmune, Inc. | -134.48 Million USD | -47.58% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 200.208% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7735.61% |
| Compugen Ltd. | -12.9 Million USD | -1438.097% |
| Peak Bio, Inc. | 10.34 Million USD | 2019.468% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -70032.862% |
| Benitec Biopharma Inc. | -50.58 Million USD | -292.385% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -90.224% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1110.313% |
| Zura Bio Limited | -99.8 Million USD | -98.862% |
| PolyPid Ltd. | 6.17 Million USD | 3316.791% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 367.777% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1110.313% |
| Instil Bio, Inc. | 75.35 Million USD | 363.377% |
| argenx SE | -2.02 Billion USD | 90.217% |
| Immunome, Inc. | -97.02 Million USD | -104.553% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -782.312% |
| Verona Pharma plc | -220.44 Million USD | 9.965% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -176.649% |
| Shattuck Labs, Inc. | -121.42 Million USD | -63.457% |
| CervoMed Inc. | -7.79 Million USD | -2446.9% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -6.996% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4438.669% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -50.657% |
| Moolec Science SA | 117.61 Thousand USD | 168849.15% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -8574.738% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1348.404% |
| AnaptysBio, Inc. | -18.15 Million USD | -993.471% |
| Design Therapeutics, Inc. | -18.15 Million USD | -993.532% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -182.002% |
| NeurAxis, Inc. | 145.7 Thousand USD | 136322.375% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1867.058% |
| Lumos Pharma, Inc. | -28.49 Million USD | -596.578% |
| Achilles Therapeutics plc | -126.92 Million USD | -56.374% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -176.649% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -30167.946% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -855.414% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13711.709% |
| Nutriband Inc. | -251.65 Thousand USD | -78767.665% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1406.917% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2567.688% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 158.341% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 936.217% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 55.645% |
| Palisade Bio, Inc. | -12.06 Million USD | -1545.329% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -41.454% |
| Beam Therapeutics Inc. | -262.72 Million USD | 24.454% |
| Neurogene Inc. | -131.95 Million USD | -50.412% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1009.773% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3967.131% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 47.381% |
| Sesen Bio, Inc. | -112.55 Million USD | -76.34% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -98.754% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -8353.727% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -408.574% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -138.318% |
| Athira Pharma, Inc. | -88.99 Million USD | -123.009% |
| Vaccinex, Inc. | -1.28 Million USD | -15309.627% |
| HCW Biologics Inc. | 2.85 Million USD | 7047.795% |
| XOMA Corporation | -29 Million USD | -584.4% |
| Nektar Therapeutics | 210.24 Million USD | 194.404% |
| Arvinas, Inc. | -313.8 Million USD | 36.751% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12329.788% |
| Merus N.V. | -192.88 Million USD | -2.899% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 430.876% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2760.709% |
| Rezolute, Inc. | -68.16 Million USD | -191.157% |
| Clene Inc. | 3.34 Million USD | 6042.395% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1405.088% |
| BeyondSpring Inc. | -13.75 Million USD | -1342.937% |
| Synlogic, Inc. | -6.68 Million USD | -2868.975% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 17602.293% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2247.439% |
| Peak Bio, Inc. | 10.34 Million USD | 2019.468% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -140.81% |
| Krystal Biotech, Inc. | -350.23 Million USD | 43.33% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 259.9% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -17.444% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -6186.568% |
| MannKind Corporation | 143.89 Million USD | 237.927% |
| Ikena Oncology, Inc. | -109.15 Million USD | -81.828% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2521.53% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -499.625% |
| Gossamer Bio, Inc. | 180.35 Million USD | 210.047% |
| CohBar, Inc. | -5.93 Million USD | -3246.569% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -567.191% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4446.824% |
| Legend Biotech Corporation | -949.39 Million USD | 79.095% |
| Mural Oncology plc | -255.84 Million USD | 22.423% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 716.098% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -4113.354% |
| Disc Medicine, Inc. | -358.28 Million USD | 44.603% |
| Champions Oncology, Inc. | 4.81 Million USD | 4224.605% |
| REGENXBIO Inc. | 54.76 Million USD | 462.394% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -73708.417% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -31.42% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2102.351% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -145.995% |
| Vaxart, Inc. | -8.24 Million USD | -2308.397% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -295.528% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -56.077% |
| Cellectis S.A. | -43.85 Million USD | -352.573% |
| Longeveron Inc. | -2.9 Million USD | -6725.172% |
| Repare Therapeutics Inc. | -107.85 Million USD | -84.016% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 120.496% |
| Inozyme Pharma, Inc. | 12 Million USD | 1753.416% |
| Revolution Medicines, Inc. | -608.2 Million USD | 67.367% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -16036.26% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 25.136% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -32.254% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1168.46% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -26721.081% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.925% |
| Denali Therapeutics Inc. | -74.86 Million USD | -165.112% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1555.111% |
| Veru Inc. | 4.77 Million USD | 4252.245% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1664.859% |
| Cingulate Inc. | 3.08 Million USD | 6538.417% |
| Passage Bio, Inc. | 4.58 Million USD | 4428.811% |
| Context Therapeutics Inc. | -14.44 Million USD | -1273.553% |
| Exicure, Inc. | 5.84 Million USD | 3493.332% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 13.847% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -401.582% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1364.903% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -237.424% |
| Nuvalent, Inc. | -335.38 Million USD | 40.822% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 11543.886% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -166.475% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2132.576% |
| OmniAb, Inc. | 9.2 Million USD | 2256.645% |
| Anew Medical, Inc. | 1.43 Million USD | 13955.557% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1311.567% |
| Lipocine Inc. | -4.75 Million USD | -4074.407% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -80.715% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1403.106% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -291.788% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 897.349% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2853.072% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -201.512% |
| Ocugen, Inc. | -32.52 Million USD | -510.301% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -131.932% |
| Q32 Bio Inc. | -37.94 Million USD | -423.021% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -31504.459% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1367.041% |
| Equillium, Inc. | -22.39 Million USD | -786.37% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -676.267% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -508.323% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -79958.084% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 248.07% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 6306.254% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 60529.727% |
| Dominari Holdings Inc. | 195 Thousand USD | 101882.564% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3668.358% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2125.816% |
| Bio-Techne Corporation | 267.74 Million USD | 174.128% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1124.48% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -68.066% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2261.966% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1468.856% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 19.029% |
| Nkarta, Inc. | 57.29 Million USD | 446.386% |
| BioCardia, Inc. | 212 Thousand USD | 93720.755% |
| Iterum Therapeutics plc | 13.43 Million USD | 1576.976% |